Skip to application
All calculators and tools

Preparation. Administration. Evidence.

IV Dilution &
Medication Reference

Search 255 medications, read preserved historical references, and inspect separately reviewed preparation statements. Full monograph updates remain pending.

Version 6.4Release date 2026-11-04For healthcare professionals

Promethazine

Review note before using historical content

Promethazine historical concentration and infusion advice is superseded

The restored article already warns against IV push, but other concentration and infusion-time examples conflict with the later FDA labeling update. Deep intramuscular administration is preferred; if IV administration is necessary, follow the updated exact-product dilution and infusion instructions. Do not use the old maximum-IV-concentration sentence or infusion examples as current instructions.

Safety sources and review scope
  • FDA class-wide promethazine labeling safety update (opens in a new tab)Source URL: https://www.fda.gov/drugs/drug-alerts-and-statements/fda-requires-updates-labeling-promethazine-hydrochloride-injection-products

    Exact location: 2023-12-27 notice: administration recommendation paragraph; If intramuscular injection is not possible bullets; adult and pediatric dilution/infusion tables

    Source family: FDA class-wide promethazine labeling safety update

    Scope: Official route/concentration/administration update; not a complete individual product monograph.

  • Promethazine U.S. prescribing information implementing FDA update (opens in a new tab)Source URL: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1d02d52b-84bb-4e81-b352-125029eb39f6

    Exact location: CONTRAINDICATIONS UUID0e9dd230-b07d-cda7-e063-6394a90ae084; DOSAGE AND ADMINISTRATION UUID0eade268-8023-e418-e063-6294a90a6ff9, Important Administration Information and Preparation/Administration for Diluted IV Infusion, Tables1/2

    Source family: Promethazine U.S. prescribing information implementing FDA update

    Scope: Example updated SPL version8 effective2024-01-05. It confirms the label change; stocked manufacturer/package and latest marketing status remain unreconciled.

Historical source in disagreement: Archived GlobalRPh article (opens in a new tab)Historical source URL: https://globalrph.com/dilution/promethazine/

Historical location: Drug Dilution:15–30 minute examples; Stability/Miscellaneous: Limit concentration paragraph and historical ISMP strategies

Review-note ID: H62-SAFETY-PROMETHAZINE-ADMINISTRATION. The historical source remains preserved; this note does not qualify its complete monograph.

Historical source. Current clinical review is incomplete. This monograph will be updated in the future.

Promethazine (opens in a new tab)Original source URL: https://globalrph.com/dilution/promethazine/ | Retrieved 2026-11-04

Source dates, location and integrity

This historical article is separate from the reviewed claim cards. Product formulations and source dates may differ.

Original source URL
https://globalrph.com/dilution/promethazine/ (opens in a new tab)
Source date
Not established in the retrieved source
Retrieved
2026-11-04T19:47:24.201827+00:00
Source location
div.post-content
Packaged content SHA-256
2dd4f01d4b5b9cebbd4a0fc3532d9ab8b2a155ba12f47798a9daf216ea448069
Original response SHA-256
8356be5791a8cf5f99a89fc495f637c3dd450f1a5d5c268ed747f78741912194
Source body SHA-256
c675d139591292ad2d9f3b480197f6042ee80945fbf2ea8ee47cfdacaa9fec3f

Promethazine

The authors make no claims of the accuracy of the information contained herein; and these suggested doses and/or guidelines are not a substitute for clinical judgment. Neither GlobalRPh Inc. nor any other party involved in the preparation of this document shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user's use of or reliance upon this material. PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER.

Usual Diluents

NS, D5W

Standard Dilutions [Amount of drug] [Infusion volume] [Infusion rate]

Promethazine historical concentration and infusion advice is superseded

The restored article already warns against IV push, but other concentration and infusion-time examples conflict with the later FDA labeling update. Deep intramuscular administration is preferred; if IV administration is necessary, follow the updated exact-product dilution and infusion instructions. Do not use the old maximum-IV-concentration sentence or infusion examples as current instructions.

Current-source reference: 2023-12-27 notice: administration recommendation paragraph; If intramuscular injection is not possible bullets; adult and pediatric dilution/infusion tables

Current-source reference: CONTRAINDICATIONS UUID0e9dd230-b07d-cda7-e063-6394a90ae084; DOSAGE AND ADMINISTRATION UUID0eade268-8023-e418-e063-6294a90a6ff9, Important Administration Information and Preparation/Administration for Diluted IV Infusion, Tables1/2

Follow your local protocol....
Detroit VAMC Dilution:
[0 - 25 mg] [ 50 -100 ml] [ 15 - 30 min]

Concentration studied in Trissel: (0.1 mg/ml)
[12.5 mg] [ 125 ml] [ 15 to 30 min]
[25 mg] [ 250 ml] [ 15 to 30 min]

If a patient complains of pain during intended intravenous injection, stop the injection immediately; suspect inadvertent intra-arterial injection.

Stability / Miscellaneous

Promethazine historical concentration and infusion advice is superseded

The restored article already warns against IV push, but other concentration and infusion-time examples conflict with the later FDA labeling update. Deep intramuscular administration is preferred; if IV administration is necessary, follow the updated exact-product dilution and infusion instructions. Do not use the old maximum-IV-concentration sentence or infusion examples as current instructions.

Current-source reference: 2023-12-27 notice: administration recommendation paragraph; If intramuscular injection is not possible bullets; adult and pediatric dilution/infusion tables

Current-source reference: CONTRAINDICATIONS UUID0e9dd230-b07d-cda7-e063-6394a90ae084; DOSAGE AND ADMINISTRATION UUID0eade268-8023-e418-e063-6294a90a6ff9, Important Administration Information and Preparation/Administration for Diluted IV Infusion, Tables1/2

EXP: 1 DAY (RT)
Label: Do not Refrigerate. Protect from light.
If a patient complains of pain during intended intravenous injection, stop the injection immediately. DO NOT GIVE IV PUSH - MUST DILUTE FIRST AND ADMINISTER BY SLOW IV INFUSION- SEE BELOW. PREFERRED ROUTES: IM OR ORAL.

Subcutaneous or intra-arterial injection is contraindicated as these routes of administration may cause tissue necrosis and gangrene of the affected extremity, respectively (Prod Info Phenergan(R),).

Dilution opinion (D. McAuley):
A 10-fold dilution will result in a negligible change in the pH ( ~+ 0.3). NaCl is the salt of a strong acid and strong base and has a neutral pH. Promethazine is considered a weak acid and is only partially dissociated in solution. The degree of dissociation is proportional to its Ka (dissociation constant). Larger Ka --> stronger acid (greater dissociation). What does all this mean?? 1) The pH of promethazine after a 10-fold dilution (or greater) is still quite low. 2) The primary purpose of the dilution is to facilitate a slower administration rate and to reduce the amount of drug present per unit of volume.

Dosing (Adults): (Preferred routes: oral or IM). If administered IV, dilute drug and administer slowly as indicated above.
Allergic conditions (including allergic reactions to blood or plasma): Oral, rectal: 25 mg at bedtime or 12.5 mg before meals and at bedtime (range: 6.25 to 12.5 mg 3 times/day). I.M., I.V.: 25 mg, may repeat in 2 hours when necessary; switch to oral route as soon as feasible.

Antiemetic: Oral, I.M., I.V., rectal: 12.5 to 25 mg every 4 to 6 hours as needed.
Sedation: Oral, I.M., I.V., rectal: 12.5 to 50 mg/dose.

--------------------------------------------------------------------------------

Background information:

Title: Action needed to prevent serious tissue injury with IV promethazine.

"ISMP believes these long-standing hazards require further action on the part of healthcare providers, FDA, and promethazine manufacturers. In the 1970s, after numerous reports of infiltration and inadvertent intraarterial injection of hydroxyzine, FDA asked the manufacturer to revise the label and remove IV as an approved route. Today the drug is only indicated for IM or oral administration. Similarly, FDA should carefully investigate adverse events with this drug to determine if labeling changes are warranted, including removal of approval for IV administration."

Safe Practice Recommendations: ... [See ISMP for further info ] Limited direct quotes from this source.

Along with the manufacturer recommendations, the following strategies should be considered to prevent or minimize tissue damage when giving IV promethazine.... [See ISMP for further info ]

Limit concentration. Since 25 mg/mL is the highest concentration of promethazine that can be given IV, stock only this concentration (not the 50 mg/mL concentration). Limit the dose. Consider 6.25 to 12.5 mg of promethazine as the starting IV dose, especially for elderly patients. Hospitals have reported that these smaller doses have proven quite effective. Dilute the drug. Require further dilution of the 25 mg/mL strength to reduce vesicant effects and enable slow administration. For example, dilute the drug in 10 to 20 mL of normal saline if it will be administered via a running IV, or prepare the medication in minibags containing normal saline if there is time for pharmacy to dispense them as needed for individual patients. Extravasation can also be recognized more quickly when promethazine is diluted than if the drug is given in a smaller volume. Use large patent veins. Give the medication only through a large-bore vein (preferably via a central venous access site, but absolutely no hand or wrist veins). Check patency of the access site before administration... [See ISMP for further info ] Inject into the furthest port. Administer IV promethazine through a running IV line at the port furthest from the patient's vein. Educate patients. Before administration of the drug, tell patients to let you know immediately if burning or pain occurs during or after the injection. Use alternatives. Consider safer alternatives that can be used for the various conditions treated with IV promethazine. For example, 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists may be used for both prophylaxis and as a rescue antiemetic. ... [See ISMP for further info ] Remove from formulary. Some hospitals that have continued to experience adverse outcomes despite safety measures have removed promethazine from their formulary or banned its IV use.The above message comes from "ISMP", who is solely responsible for its content.

Nursing forum responses (Various sources - original sources unknown)
"At my hospital the doc's usually write for 6.25mg-12.5mg at a time. We give the full 25mg very rarely. I dilute it in 10cc NS and if fluids are running I hang it as a secondary over 10-20 minutes depending on the pt's vein status. I've pushed it diluted over 5 minutes before and it caused chemical phlebitis."

--------------------------------------------------------------------------------

"Mosby's drug guide for nurses states to dilute with 9ml NaCl and administer over 2 minutes. Always dilute phenergan when giving it IV. My DH was in ER a while ago for what turned out to be food poisoning, they gave him undiluted phenergan and his vein sclerosed from wrist to bicep (no I'm NOT exaggerating)"

--------------------------------------------------------------------------------

"As a nurse, I have had many patients complain aobut how much Phenergan burns. I would always just politely tell them them that it would burn and then push it slow diluted in 10 cc's of NS but then it was my turn. I was hospitalized and was given IV Phenergan and it not only burned like heck but I swear I felt like I was having a full blown MI. My entire arm was numb not to mention the IV site had to be changed and I developed phlebitis all around the site. I don't give Phenergan anymore without diluting it in 50 cc's of NS. I learned my lesson."

Matching medication records

Return to top